Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Berahovich

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|January 11, 2017
Major Highlights of the CAR-TCR Summit, Boston, 2016Vita Golubovskaya, Robert Berahovich, Shirley Xu, et al.
Cancers|May 5, 2019
Hypoxia Selectively Impairs CAR-T Cells In VitroRobert Berahovich, Xianghong Liu, Hua Zhou, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Generation of CAR-T Cells for Cancer ImmunotherapyQumiao Xu, Hizkia Harto, Robert Berahovich, et al.
Cancers|October 26, 2017
CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor GrowthVita Golubovskaya, Robert Berahovich, Hua Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23Zhenhua Miao, Brett A Premack, Zheng Wei, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells <i>in vitro</i> and <i>in vivo</i>Robert Berahovich, Shirley Xu, Hua Zhou, et al.
Frontiers in Bioscience (Landmark Edition)|May 18, 2018
GITR domain inside CAR co-stimulates activity of CAR-T cells against cancerVita M Golubovskaya, Robert Berahovich, Qumiao Xu, et al.
International Journal of Molecular Sciences|September 9, 2023
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In VivoVita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Frontiers in Bioscience (Landmark Edition)|October 6, 2019
Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells <i>in vitro</i> and <i>in vivo</i>Michael Valentine, Le Li, Hua Zhou, et al.
Biomedicines|October 23, 2021
Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple MyelomaVita Golubovskaya, Hua Zhou, Feng Li, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Anti-Cancer Agents in Medicinal Chemistry|January 11, 2017
Major Highlights of the CAR-TCR Summit, Boston, 2016Vita Golubovskaya, Robert Berahovich, Shirley Xu, et al.
Cancers|May 5, 2019
Hypoxia Selectively Impairs CAR-T Cells In VitroRobert Berahovich, Xianghong Liu, Hua Zhou, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Generation of CAR-T Cells for Cancer ImmunotherapyQumiao Xu, Hizkia Harto, Robert Berahovich, et al.
Cancers|October 26, 2017
CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor GrowthVita Golubovskaya, Robert Berahovich, Hua Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23Zhenhua Miao, Brett A Premack, Zheng Wei, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells <i>in vitro</i> and <i>in vivo</i>Robert Berahovich, Shirley Xu, Hua Zhou, et al.
Frontiers in Bioscience (Landmark Edition)|May 18, 2018
GITR domain inside CAR co-stimulates activity of CAR-T cells against cancerVita M Golubovskaya, Robert Berahovich, Qumiao Xu, et al.
International Journal of Molecular Sciences|September 9, 2023
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In VivoVita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Frontiers in Bioscience (Landmark Edition)|October 6, 2019
Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells <i>in vitro</i> and <i>in vivo</i>Michael Valentine, Le Li, Hua Zhou, et al.
Biomedicines|October 23, 2021
Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple MyelomaVita Golubovskaya, Hua Zhou, Feng Li, et al.
Pageof 2